Agents, Uses and Methods for Treatment

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20170267761A1
SERIAL NO

15207880

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to monoclonal anti-Sortilin antibodies which have been found useful in correcting a deficient level of progranulin (PGRN). In particular, these antibodies can be used in the treatment of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
H LUNDBECK A/SDENMARK VALBY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Biilmann, Rønn Lars Christian Valby, DK 6 27
Christensen, Søren Valby, DK 25 171
de, Jong Rob Utrecht, NL 20 56
Egebjerg, Jan Valby, DK 9 35
Gerritsen, Arnout Utrecht, NL 7 142
Malik, Ibrahim John Valby, DK 19 173
Parren, Paul Utrecht, NL 234 3032
Stavenhagen, Jeffrey B Valby, DK 24 485
van, den Brink Edward Utrecht, NL 38 279

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation